Neelim للاستشارات الصحية
Neelim

Free Pharmacist mock test

25 original exam-style questions from our Pharmacist bank, timed at the exam’s own pace, scored against the 60% DHA pass mark. They span 13 of the 13 blueprint domains, so you will see exactly where you are weakest - free, no sign-up.

DHA PHO5481OMSB OEPPass mark DHA 60% · DOH Pass / fail only · SCFHS 536 on a 200-800 scale · QCHP 60% · OMSB 60%

Free diagnosticNo sign-up · no email · results instantly

Sit 25 original exam-style questions at real exam pace

These are 25 original questions taken from our Pharmacist bank, spread across 13 of the 13 domains of the published blueprint. You get 72 seconds per question, which is exactly the pace of the real PHO5481 exam (30 minutes for 25). At the end you will see which domains you are weakest in, and the full worked reasoning for every question.

25
questions
30:00
time limit
60%
DHA pass mark

A short diagnostic cannot predict whether you will pass - only the real exam does that. It will show you, honestly, where you currently stand.

Quick answer

The Pharmacist exam at a glance

The Pharmacist licensing exam is a computer-based, multiple-choice test, and each GCC regulator sets its own. DHA, DOH, SCFHS, QCHP and OMSB publish exact figures, listed below. This free mock gives you 25 original exam-style questions at 72 seconds each, scored against the 60% DHA pass mark, then shows your weakest domains.

Published exam figures

  • DHA

    Pharmacist (PHO5481)

    UAE150 MCQs3 hours

    60%

    pass mark

  • DOH

    Pharmacist CBT

    UAE50-100 MCQs1-2 hours

    Pass / fail only

    pass mark

  • SCFHS

    Saudi Pharmacist Licensure Examination (SPLE)

    Saudi Arabia200 MCQs240 minutes

    536 on a 200-800 scale

    pass mark

  • QCHP

    Pharmacist

    Qatar150 MCQs3 hours

    60%

    pass mark

  • OMSB

    Omani Examination for Pharmacists (OEP)

    Oman100 MCQs150 minutes

    60%

    pass mark

Attempts in the UAE
3 in total across DHA, DOH, MOHAP and SHA
This free mock
25 questions · 30 minutes · 13 of 13 domains
Full bank
405+ questions · 3 to 6 papers · AED 269
Regulators
DHA, DOH, SCFHS, QCHP, OMSB, MOHAP, SHA, NHRA and Kuwait MOH

How this free Pharmacist mock works

25
original questions
30 min
time limit
72s
per question
13 of 13
blueprint domains
  • You get 72 seconds per question, the pace of a 150-question paper in 3 hours. The timer runs in your browser and ends the sitting when it reaches zero.
  • Your score is set against the 60% DHA pass mark, the published figure for this exam. No other number is invented: there is no percentile and no pass probability.
  • At the end you see your score, your pace per question, every domain ranked weakest first, and the worked answer and source for all 25 questions.
  • You can mark each answer “sure” or “not sure”. Wrong answers you were sure about are shown first, because they are the ones you would not stop to check in the real exam.
  • Your last result is saved in your own browser only, so you can come back and compare. Nothing is sent to us.

What the real Pharmacist licensing exam looks like

The Pharmacist exam is a computer-based multiple-choice paper, published by 5 regulators: DHA PHO5481 (pass mark 60%), DOH (pass mark Pass / fail only), SCFHS SPLE (pass mark 536/800), QCHP (pass mark 60%), OMSB OEP (pass mark 60%). Every regulator's format, pass mark and fee is in the table below; confirm yours before booking.

Pass marks at a glance: exam codes and pass marks by regulator for every written exam in one sourced table.

Before you can book the exam at all you need Dataflow primary source verification of your degree, licence and experience, which typically runs several weeks. Candidates often underestimate this and end up sitting the exam sooner after study than they planned. Check where you stand with our free eligibility checker or confirm whether your title even requires an exam using the Prometric exam checker.

You get three attempts in total across all UAE authorities, not three each, under the Unified Professional Qualification Requirements. At roughly AED 880 per attempt, plus the licensing delay each failure adds to your visa and start date, the cost of going in underprepared is not really the exam fee.

Pharmacist licensing exam in every GCC country
RegulatorExamFormatPass markFee per attempt
Pharmacist (PHO5481)
150 MCQs in 3 hours60%USD 240 (about AED 880)
DOH
Abu Dhabi, Al Ain and Al Dhafra
Practise →
Pharmacist CBT
50-100 MCQs in 1-2 hoursPass / fail onlyAED 550
SCFHS
Kingdom of Saudi Arabia
Practise →
200 MCQs in 240 minutes536 on a 200-800 scaleNot published
QCHP
State of Qatar
Practise →
Pharmacist
150 MCQs in 3 hours60%Not published
OMSB
Sultanate of Oman
Practise →
Omani Examination for Pharmacists (OEP)
100 MCQs in 150 minutes60%USD 200 (about OMR 80)
MOHAP
Northern Emirates - Ajman, Umm Al Quwain, Ras Al Khaimah and Fujairah
Practise →
MOHAP licensing exam
Regulator-wide format
Computer-basedNot publishedNot published
SHA
Emirate of Sharjah
Practise →
SHA licensing exam
Regulator-wide format
Set at assessmentNot publishedNot published
NHRA
Kingdom of Bahrain
Practise →
NHRA licensing exam
Regulator-wide format
Prometric CBTNot publishedNot published
Kuwait MOH
State of Kuwait
Practise →
No exam published for this title
Kuwait MOH publishes no exam for this title; check with the MOH
Not publishedNot publishedNot published

Highlighted rows publish figures for this exact Pharmacist exam; the others show the regulator's general rules.

What is on the Pharmacist exam: the full blueprint

The published blueprint splits into 13 domains and 183 testable sub-topics. For each one you can see its weight, how many questions this mock asks on it, and about how many the full bank holds.

  • Clinical Therapeutics & Disease-State Management~30%

    22 sub-topics · 4 in this mock · about 148 in the full bank

    DHA lists 'Pharmaceutical Care & Disease State Management' at 35%; SCFHS Clinical Sciences 35%

  • Pharmacology, Drug Classes, ADRs & Drug Interactions~12%

    15 sub-topics · 1 in this mock · about 59 in the full bank

    est.; core of SCFHS Pharmaceutical Sciences 35%

  • Pharmaceutical Calculations & Compounding~12%

    15 sub-topics · 1 in this mock · about 59 in the full bank

    DHA 'Pharmacy Calculation & Compounding' 15%; SCFHS Sterile/Nonsterile Compounding

  • Pharmaceutics, Biopharmaceutics & Pharmacokinetics~8%

    15 sub-topics · 1 in this mock · about 40 in the full bank

    est.; SCFHS Pharmaceutics 2.4 & Pharmacokinetics 2.5

  • Medicinal Chemistry, Pharmacognosy & Dietary Supplements~6%

    11 sub-topics · 3 in this mock · about 30 in the full bank

    est.; SCFHS Medicinal Chemistry 2.1 & Pharmacognosy 2.3

  • Basic Biomedical Sciences~6%

    13 sub-topics · 4 in this mock · about 30 in the full bank

    SCFHS Basic Biomedical Sciences 10%

  • Nonprescription (OTC) & Self-Care / Counter Medication~6%

    12 sub-topics · 3 in this mock · about 30 in the full bank

    DHA 'Counter Medication' 10%

  • Special Populations~5%

    12 sub-topics · 1 in this mock · about 25 in the full bank

    DHA lists Pregnancy/Lactation 5%, Pediatrics 5%, Geriatrics 5%

  • Toxicology & Poisoning Management~5%

    12 sub-topics · 1 in this mock · about 25 in the full bank

    DHA Toxicology 5%; SCFHS acute/chronic toxicity

  • Patient Assessment, Counseling, Drug Information & Evidence-Based Practice~5%

    14 sub-topics · 3 in this mock · about 25 in the full bank

    est.; SCFHS Clinical 4.1, 4.5 & Professional Communication 3.8

  • Pharmacy Law, Ethics & Regulatory Affairs~6%

    14 sub-topics · 1 in this mock · about 30 in the full bank

    DHA Law & Ethics 10%; SCFHS 3.5 & 3.7

  • Public Health, Pharmacoeconomics, Pharmacoepidemiology & Biostatistics~5%

    14 sub-topics · 1 in this mock · about 25 in the full bank

    est.; SCFHS Social/Behavioral/Administrative 3.1-3.3, 3.6

  • Pharmacy Practice Management, Medication Safety & Dispensing Systems~5%

    14 sub-topics · 1 in this mock · about 25 in the full bank

    DHA Medication Safety 5%; SCFHS 3.4 & 3.10

Bank counts are estimates from the published weights the bank is written to, rounded.

This mock samples 13 of 13 domains. The full bank covers all 13 across 405+ questions.

See the full bank - AED 269

How to use your mock score

These bands are set against the 60% DHA pass mark and match the verdict on your result screen. On 25 questions, a score near the pass mark has a 95% margin of error of about ±19 points, so treat the band as a direction, not a forecast.

Below 55%

Below the line

On this sample you would likely fall short of the 60% pass mark today. Do not book yet. Start with your two weakest domains from the result, then sit full-length papers until you clear the line with room to spare.

55% to 69%

Close to the line

A few questions decide it. On a 135-question paper, every 1% is one or two questions, so drill your weakest domains and build a margin on timed papers before you book.

70% and above

On track

Clear of the pass mark on this sample. 25 questions is a small sample, so confirm it over full-length timed papers before you book: stamina and pacing fail candidates who know the material.

Getting an honest score

  1. 1Sit it cold, once. Do not look anything up. A diagnostic you help yourself through tells you nothing. The number you get is only useful if it is honest.
  2. 2Read every rationale, especially the ones you got right. Getting a question right by elimination is not the same as knowing it. The worked reasoning is free, whether or not you buy anything.
  3. 3Work on your weakest domain first. The breakdown orders your domains worst first for exactly this reason. Studying what you are already good at feels productive and moves nothing.
  4. 4Re-sit under full exam conditions later. The real paper is much longer than 25 questions and stamina matters. The full bank's 3 to 6 papers are written for exactly this.

A worked Pharmacist exam question

Every question in the mock and in the paid bank is written to this standard: a clinical stem, four plausible options and the reasoning for the answer, with its source.

Public Health, Pharmacoeconomics, Pharmacoepidemiology & Biostatistics

A pharmacist wants to improve adherence in a patient ambivalent about starting a statin. Which counseling approach is most consistent with evidence-based behavior change and respects patient autonomy?

  1. AWarning the patient repeatedly about death to induce fear
  2. BMotivational interviewing to explore the patient's own reasons for changeCorrect
  3. CRefusing to dispense unless the patient agrees to lifelong therapy
  4. DProviding a detailed pharmacology lecture on statin mechanism

Why: Motivational interviewing is a collaborative, patient-centered approach that helps resolve ambivalence by eliciting the patient's own motivations, and it improves adherence while respecting autonomy. Fear-based repetition, coercive refusal to dispense, and dense pharmacology lectures are not patient-centered, tend to raise resistance, and are not evidence-based methods for supporting sustained behavior change.

Source: Miller & Rollnick, Motivational Interviewing (foundational); WHO Adherence to Long-Term Therapies (2003)

Pharmacist sample questions with answers

10 more original exam-style Pharmacist questions, worked in full. They are not real or recalled exam questions, and none of them is in the mock above or on the bank page, so sit the mock first if you have not.

  1. Question 1 · Pharmacology, Drug Classes, ADRs & Drug Interactions

    A non-diabetic patient with heart failure with reduced ejection fraction is prescribed dapagliflozin. Which statement about this indication is correct?

    1. AIt is approved only for glycemic control and has no role in heart failure
    2. BIt is contraindicated in any patient without diabetes
    3. CIt is approved to reduce cardiovascular death and heart-failure hospitalization in HFrEF, including non-diabetics
    4. DIt is indicated exclusively for type 1 diabetes
    Show answer and explanation

    Correct answer: C. It is approved to reduce cardiovascular death and heart-failure hospitalization in HFrEF, including non-diabetics

    SGLT2 inhibitors such as dapagliflozin are approved to reduce cardiovascular death and heart-failure hospitalization in patients with HFrEF regardless of diabetes status, based on trials like DAPA-HF. They are not restricted to diabetics, are not contraindicated in non-diabetics, and are not indicated for type 1 diabetes management.

    Reference: 2022 AHA/ACC/HFSA Heart Failure Guideline; DAPA-HF trial (NEJM 2019)

  2. Question 2 · Pharmaceutics, Biopharmaceutics & Pharmacokinetics

    Many recombinant protein products, such as filgrastim and monoclonal antibodies, must be stored refrigerated and protected from agitation. What is the main stability concern this handling addresses?

    1. APhotolysis of aromatic side chains
    2. BOxidation of the polymeric coating
    3. CPhysical instability such as denaturation and aggregation of the protein
    4. DRacemization of the sugar backbone
    Show answer and explanation

    Correct answer: C. Physical instability such as denaturation and aggregation of the protein

    Therapeutic proteins are prone to physical instability including unfolding (denaturation) and aggregation, which are accelerated by heat and mechanical stress such as shaking, and aggregates can reduce potency and increase immunogenicity. Refrigeration and gentle handling limit these processes; photolysis, coating oxidation, and sugar racemization are not the primary aggregation-related concerns for these products.

    Reference: Crommelin, Pharmaceutical Biotechnology: Fundamentals and Applications, 5th ed., 2019

  3. Question 3 · Basic Biomedical Sciences

    In a purine base found in DNA, which structural feature distinguishes purines from pyrimidines?

    1. AA single six-membered nitrogen-containing ring
    2. BA fused double-ring system (a pyrimidine ring fused to an imidazole ring)
    3. CA ribose sugar instead of deoxyribose
    4. DThe presence of a methyl group at position 5
    Show answer and explanation

    Correct answer: B. A fused double-ring system (a pyrimidine ring fused to an imidazole ring)

    Purines (adenine and guanine) have a bicyclic structure consisting of a six-membered pyrimidine ring fused to a five-membered imidazole ring. Pyrimidines (cytosine, thymine, uracil) have only a single six-membered ring. The sugar type distinguishes DNA from RNA, not purines from pyrimidines, and a 5-methyl group specifically characterizes thymine.

    Reference: Lehninger Principles of Biochemistry, 8th ed., 2021

  4. Question 4 · Pharmacy Law, Ethics & Regulatory Affairs

    A pharmacist-investigator plans a trial enrolling adults who lack decision-making capacity. Which safeguard is most consistent with research ethics standards?

    1. AProceed without consent because the participants cannot object
    2. BObtain consent from a legally authorized representative, ensure the research cannot be done in a capable population, and obtain ethics committee approval
    3. CEnroll them only if the sponsor pays a higher fee
    4. DRely on verbal agreement from other patients in the ward
    Show answer and explanation

    Correct answer: B. Obtain consent from a legally authorized representative, ensure the research cannot be done in a capable population, and obtain ethics committee approval

    Research with participants lacking capacity requires consent from a legally authorized representative, justification that the research cannot instead be conducted in a capable population, additional protections, and independent ethics committee approval. Proceeding without consent, basing enrollment on sponsor fees, or relying on unrelated patients' agreement all violate the protections owed to vulnerable participants.

    Reference: World Medical Association Declaration of Helsinki (2013); ICH Good Clinical Practice E6(R2) (2016)

  5. Question 5 · Toxicology & Poisoning Management

    A patient receiving high cumulative doses of doxorubicin for chemotherapy is at greatest risk of which dose-dependent organ toxicity, and which agent is used to reduce it?

    1. ANephrotoxicity; prevented by mesna
    2. BDilated cardiomyopathy/heart failure; risk reduced by dexrazoxane
    3. CHepatotoxicity; prevented by N-acetylcysteine
    4. DOtotoxicity; prevented by amifostine
    Show answer and explanation

    Correct answer: B. Dilated cardiomyopathy/heart failure; risk reduced by dexrazoxane

    Anthracyclines such as doxorubicin cause dose-dependent, potentially irreversible cardiotoxicity (dilated cardiomyopathy and heart failure), and dexrazoxane is an iron-chelating cardioprotectant used to reduce this risk. Mesna prevents ifosfamide/cyclophosphamide hemorrhagic cystitis, not anthracycline cardiotoxicity.

    Reference: ESMO/ASCO cardio-oncology guidance; DiPiro Pharmacotherapy, 11th ed.

  6. Question 6 · Public Health, Pharmacoeconomics, Pharmacoepidemiology & Biostatistics

    In a trial, the event rate is 20% with placebo and 15% with a new drug. What is the number needed to treat (NNT) to prevent one event?

    1. A5
    2. B20
    3. C10
    4. D25
    Show answer and explanation

    Correct answer: B. 20

    The absolute risk reduction is 20% minus 15%, which equals 5% or 0.05. The NNT is the reciprocal of the absolute risk reduction, so 1 divided by 0.05 equals 20. Values such as 5, 10, or 25 result from incorrect arithmetic or from confusing NNT with relative risk reduction.

    Reference: Guyatt et al., Users' Guides to the Medical Literature (current)

  7. Question 7 · Clinical Therapeutics & Disease-State Management

    A 40-year-old man with bipolar disorder maintained on lithium develops vomiting, coarse tremor, confusion, and ataxia. He recently started a new medication for hypertension. Which co-prescribed drug most likely precipitated lithium toxicity by reducing its renal clearance?

    1. AAmlodipine
    2. BHydrochlorothiazide
    3. CDoxazosin
    4. DHydralazine
    Show answer and explanation

    Correct answer: B. Hydrochlorothiazide

    Thiazide diuretics such as hydrochlorothiazide reduce renal lithium clearance by increasing proximal tubular reabsorption of sodium and lithium, leading to elevated lithium levels and toxicity manifest as tremor, ataxia, and confusion. Amlodipine, doxazosin, and hydralazine do not significantly impair lithium clearance.

    Reference: Lithium prescribing information; standard pharmacotherapy and drug-interaction references

  8. Question 8 · Pharmaceutical Calculations & Compounding

    A 1 g antibiotic vial must yield a final volume of 4 mL after reconstitution. If the powder displacement volume is 0.7 mL, what volume of diluent should be added?

    1. A0.7 mL
    2. B3.3 mL
    3. C4 mL
    4. D4.7 mL
    Show answer and explanation

    Correct answer: B. 3.3 mL

    Diluent volume = final volume − displacement volume = 4 mL − 0.7 mL = 3.3 mL. Adding the full 4 mL would ignore the powder's own volume and overfill the vial.

    Reference: Ansel's Pharmaceutical Calculations, 15th ed. (2017)

  9. Question 9 · Medicinal Chemistry, Pharmacognosy & Dietary Supplements

    A neonate is at higher risk of chloramphenicol-induced gray baby syndrome. The underlying metabolic explanation is an immature capacity for which Phase II reaction?

    1. ASulfation
    2. BAcetylation
    3. CGlucuronidation
    4. DGlutathione conjugation
    Show answer and explanation

    Correct answer: C. Glucuronidation

    Neonates have immature UDP-glucuronosyltransferase activity, so glucuronidation is deficient; chloramphenicol, which is normally inactivated by glucuronide conjugation, accumulates to toxic levels causing gray baby syndrome (cardiovascular collapse). Sulfation is relatively well developed at birth and partly compensates for other drugs, while acetylation and glutathione conjugation are not the rate-limiting deficient pathway responsible for this specific toxicity.

    Reference: Goodman & Gilman's The Pharmacological Basis of Therapeutics, 13th ed. (2018)

  10. Question 10 · Nonprescription (OTC) & Self-Care / Counter Medication

    An OTC weight-management product contains orlistat 60 mg. Which counseling point is essential for a patient starting it?

    1. AIt suppresses appetite centrally, so take it on an empty stomach
    2. BIt blocks dietary fat absorption and can cause oily/loose stools; take a multivitamin at bedtime
    3. CIt is safe to take with a very high-fat diet without GI effects
    4. DIt should be combined with a stimulant laxative for best results
    Show answer and explanation

    Correct answer: B. It blocks dietary fat absorption and can cause oily/loose stools; take a multivitamin at bedtime

    Orlistat inhibits pancreatic lipase, blocking absorption of about a quarter of dietary fat, which can cause steatorrhea, oily spotting, and fecal urgency, and it reduces absorption of fat-soluble vitamins, so a multivitamin taken at bedtime (separated from doses) is advised. It is not a central appetite suppressant, GI effects worsen with high-fat meals, and adding a stimulant laxative is inappropriate.

    Reference: Orlistat 60 mg OTC labeling; NICE weight management guidance

Last reviewed September 2026. About these questions: every item is original, written to the published blueprint, with a rationale and a reference, and no recalled or leaked exam content is used. How we write our questions.

Free mock vs the full Pharmacist bank

The mock tells you where you stand. The bank is how you close the gap.

Free Pharmacist mock compared with the full bank
What you getFree mockFull bank
Questions25405+
Papers1 short timed set3 to 6 full-length papers, about 135 each
Blueprint coverage13 of 13 domainsAll 13 domains, 183 sub-topics
Worked rationaleEvery questionEvery question
ReferenceEvery questionEvery question
Timing30 minutes in your browserExam-length papers to sit against the clock
FormatOnline, freePDF sent to you, yours to keep
PriceFreeAED 269, paid once

Full Pharmacist bank

Close your gaps before exam day

  • 405+ original questions in 3 to 6 full-length papers
  • A worked rationale and a reference on every question
  • Prepared for your regulator's blueprint and pass mark

One-time price

AED 269

About a third of one exam fee (about AED 880 per attempt)

Unlock the full bank →

No subscription · yours to keep

Frequently asked questions

Is this Pharmacist mock test really free?
Yes. All 25 questions, your score, the domain breakdown and the full worked answers are free, with no sign-up, no email and no payment. The paid Pharmacist bank is a separate, much larger set of 405+ questions across 3 to 6 papers at AED 269.
Are these real Pharmacist exam questions?
No. They are original questions written to the published Pharmacist blueprint and drawn from our full bank, not leaked or recalled items. Recalled questions breach exam security rules and are often out of date. These follow the exam's format and domain weighting.
What is the pass mark for the Pharmacist exam?
By regulator: DHA PHO5481 (pass mark 60%), DOH (pass mark Pass / fail only), SCFHS SPLE (pass mark 536/800), QCHP (pass mark 60%), OMSB OEP (pass mark 60%), each from the regulator's own exam documents. Regulators not listed publish no figure for this exam, so confirm yours before booking. Most report only pass or fail and never release your score, which is why a diagnostic like this is useful.
How long is the Pharmacist exam and how many questions?
DHA: 150 MCQs in 3 hours; DOH: 50-100 MCQs in 1-2 hours; SCFHS: 200 MCQs in 240 minutes; QCHP: 150 MCQs in 3 hours; OMSB: 100 MCQs in 150 minutes, from each regulator's own exam documents (DHA's time includes registration and the introduction, per the DHA CBT Guideline, Sep 2026). Regulators not listed publish no length for this exam, so confirm theirs in the current candidate bulletin.
What topics does the Pharmacist exam cover?
The published blueprint has 13 domains and 183 testable sub-topics. The heaviest are Clinical Therapeutics & Disease-State Management (~30%), Pharmacology, Drug Classes, ADRs & Drug Interactions (~12%) and Pharmaceutical Calculations & Compounding (~12%). The full domain list with weights is on this page.
How is the full Pharmacist bank different from this mock?
This mock is 25 questions across 13 of the 13 blueprint domains, enough to rank your domains. The full bank is 405+ questions in 3 to 6 full-length papers of about 135 questions, covering every domain, with about 148 questions on Clinical Therapeutics & Disease-State Management alone. Every question has a worked rationale and a reference. It costs AED 269, paid once.
What score should I aim for on this Pharmacist mock?
Aim for at least 70%, which is 10 points over the 60% DHA pass mark. Below 55% you would likely fall short today; between 55% and 69% a few questions decide it. On 25 questions a score near the pass mark has a margin of error of about ±19 points, so read it as a direction.
Does passing this mock mean I will pass the real exam?
No, and we will not claim otherwise. 25 questions cannot predict a full-length paper: the margin of error is about ±19 points. What it does reliably show is which blueprint domains you are weakest in, so you know where to start.
Which regulators is this Pharmacist mock for?
It is written to the shared Pharmacist blueprint, so it fits DHA, DOH, SCFHS, QCHP, OMSB, MOHAP, SHA, NHRA and Kuwait MOH. DHA, DOH, SCFHS, QCHP and OMSB publish an exam for this exact title. What changes by regulator is the length, the pass mark and the local regulation questions.
How many attempts do I get at the real exam?
In the UAE, three in total across DHA, DOH, MOHAP and SHA under the Unified Professional Qualification Requirements, not three per authority. Each attempt costs roughly AED 880, which is why it pays to find your weak domains first.

Other free mock exams

From a 25-question mock to the full Pharmacist bank

405+ original questions in 3 to 6 full-length papers, each with a worked rationale and a reference, written to the same blueprint as the free mock on this page. One price: AED 269.